Aliases & Classifications for Contact Dermatitis

Summaries for Contact Dermatitis

MalaCards based summary : Contact Dermatitis, also known as contact dermatitis/eczema, is related to rosacea and pulpitis, and has symptoms including exanthema and pruritus. An important gene associated with Contact Dermatitis is IL31 (Interleukin 31), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Bacitracin and Hydrocortisone have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and t cells, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and hematopoietic system

Wikipedia : 71 Contact dermatitis is a type of inflammation of the... more...

Related Diseases for Contact Dermatitis

Diseases related to Contact Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 429)
id Related Disease Score Top Affiliating Genes
1 rosacea 30.2 IFNG IL10 IL1B SELE
2 pulpitis 29.7 IFNG IL10 TNF
3 lymphedema 29.6 ICAM1 IL1A IL1B
4 skin conditions 29.6 CXCL8 IL1A IL1B TNF
5 hepatitis 29.3 IFNG IL10 IL6 TNF
6 choroiditis 29.0 CXCL8 IL10 IL1B IL6 TNF
7 burns 28.7 CXCL8 CXCR3 IFNG IL10 IL17A IL6
8 allergic contact dermatitis 12.6
9 irritant dermatitis 12.0
10 allergic contact dermatitis of eyelid 12.0
11 occupational dermatitis 11.3
12 exanthem 11.2
13 dermatitis 11.1
14 photoallergic dermatitis 11.0
15 toxicodendron dermatitis 11.0
16 intussusception 10.4 IL1B TNF
17 pyridoxal 5'-phosphate-dependent epilepsy 10.3 IL10 TNF
18 erythema multiforme 10.3
19 hepatic encephalopathy 10.3 IL1B IL5 TNF
20 severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive 10.3 IFNG IL10 TNF
21 pseudo-meigs syndrome 10.3 FLG IL10 TNF
22 stocco dos santos syndrome 10.3 IFNG IL1B TNF
23 myoglobinuria recurrent 10.3 IFNG IL4
24 tubular renal disease-cardiomyopathy syndrome 10.3 IL10 IL4 TNF
25 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 10.3 IL1B SELE TNF
26 myofibroma 10.3 FLG IFNG IL10
27 lagophthalmos 10.3 IL10 IL4 TNF
28 papillary squamous carcinoma 10.3 FLG IL4 IL5
29 right ventricle hypoplasia 10.3 ICAM1 SELE TNF
30 vestibule of mouth cancer 10.3 IL10 IL4 TNF
31 bone peripheral neuroepithelioma 10.3 FLG IL4 IL5
32 luminal breast carcinoma 10.3 FLG IL4 IL5
33 dermatomycosis 10.3 ICAM1 SELE TNF
34 autosomal dominant deafness-onychodystrophy syndrome 10.3 IFNG IL4 TNF
35 congenital hypothyroidism 10.2 IL10 IL4 TNF
36 asymptomatic neurosyphilis 10.2 IFNG IL10 IL4
37 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.2 ICAM1 IL10 IL4
38 persistent mullerian duct syndrome 10.2 ICAM1 IL10 TNF
39 ileocolitis 10.2 ICAM1 IL1B IL4
40 cole-carpenter syndrome 1 10.2 FLG IL10 TNF
41 tungiasis 10.2 IFNG IL10 IL4
42 multiple epiphyseal dysplasia due to collagen 9 anomaly 10.2 IFNG IL4 IL5
43 chronic thromboembolic pulmonary hypertension 10.2 IFNG IL10 SELE
44 dracunculiasis 10.2 ICAM1 SELE TNF
45 acute gonococcal prostatitis 10.2 IFNG IL4 IL5
46 histoplasmosis retinitis 10.2 IL1B IL4 IL5
47 orbit alveolar rhabdomyosarcoma 10.2 IL10 IL4 IL5
48 oral cavity carcinoma in situ 10.2 IFNG IL10 IL1B
49 centronuclear myopathy 5 10.2 IFNG IL10 IL4
50 cutaneous fibrous histiocytoma 10.2 IFNG IL4 IL5

Graphical network of the top 20 diseases related to Contact Dermatitis:



Diseases related to Contact Dermatitis

Symptoms & Phenotypes for Contact Dermatitis

UMLS symptoms related to Contact Dermatitis:


exanthema, pruritus

GenomeRNAi Phenotypes related to Contact Dermatitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.77 CXCL8 ICAM1 IL10 IL17A IL1A IL1B
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.77 CXCL8 ICAM1 IL10 IL17A IL1A IL1B

MGI Mouse Phenotypes related to Contact Dermatitis:

44 (show all 11)
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.28 IL6 SELE TNF CCL17 CXCR3 ICAM1
2 homeostasis/metabolism MP:0005376 10.25 ICAM1 IFNG IL10 IL17A IL1A IL1B
3 cellular MP:0005384 10.22 CCL17 CXCR3 ICAM1 IFNG IL10 IL33
4 immune system MP:0005387 10.21 CCL17 CXCR3 ICAM1 IFNG IL10 IL17A
5 digestive/alimentary MP:0005381 10.16 ICAM1 IFNG IL10 IL17A IL33 IL4
6 cardiovascular system MP:0005385 10.15 CXCR3 ICAM1 IFNG IL10 IL1A IL1B
7 integument MP:0010771 10.06 ICAM1 IFNG IL10 IL1A IL1B IL33
8 mortality/aging MP:0010768 9.93 CXCR3 ICAM1 IFNG IL10 IL17A IL1B
9 liver/biliary system MP:0005370 9.8 SELE TNF IFNG IL10 IL4 IL5
10 neoplasm MP:0002006 9.61 CXCR3 ICAM1 IFNG IL10 IL1A IL1B
11 respiratory system MP:0005388 9.32 IFNG IL10 IL17A IL33 IL4 IL5

Drugs & Therapeutics for Contact Dermatitis

Drugs for Contact Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 332)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bacitracin Approved, Vet_approved Phase 4,Phase 3,Phase 2 1405-87-4 439542 10909430
2
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-23-7 5754 657311
3 Sodium thiosulfate Approved Phase 4,Phase 3
4
Glycerol Approved, Experimental Phase 4 56-81-5 753
5
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
6
Triamcinolone Approved, Vet_approved Phase 4,Phase 2 124-94-7 31307
7
Fluocinonide Approved, Investigational Phase 4 356-12-7 9642
8
Petrolatum Approved Phase 4,Phase 3,Phase 1,Phase 2 8009-03-8
9
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
10
Isotretinoin Approved Phase 4,Phase 3 4759-48-2 5538 5282379
11
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
12
Salicylic acid Approved, Vet_approved Phase 4 69-72-7 338
13
Cetuximab Approved Phase 4 205923-56-4 56842117 2333
14
Zinc Approved Phase 4,Phase 2 7440-66-6 32051 23994
15
Menthol Approved Phase 4 2216-51-5 16666
16
Ethanol Approved Phase 4,Phase 1 64-17-5 702
17
Dapsone Approved, Investigational Phase 4 80-08-0 2955
18
Montelukast Approved Phase 4 158966-92-8 5281040
19
Adapalene Approved Phase 4 106685-40-9 60164
20
Benzoyl peroxide Approved Phase 4 94-36-0 7187
21
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
22
Zinc oxide Approved Phase 4,Phase 2 1314-13-2
23
Pimecrolimus Approved, Investigational Phase 4,Phase 3 137071-32-0 6447131 17753757
24 Titanium dioxide Approved Phase 4 13463-67-7
25
Desoximetasone Approved Phase 4 382-67-2 5311067
26
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
27
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 1 59-30-3 6037
28
leucovorin Approved, Nutraceutical Phase 4,Phase 2 58-05-9 54575, 6560146 143
29
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
30
Butyric Acid Experimental Phase 4,Phase 3,Phase 2 107-92-6 264
31
decanoic acid Experimental Phase 4 334-48-5 2969
32 Analgesics Phase 4,Phase 3,Phase 2
33 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
34 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
35 Antidotes Phase 4,Phase 3
36 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
37 Anti-Infective Agents, Local Phase 4,Phase 3,Phase 2
38 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
39 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2
40 Antioxidants Phase 4,Phase 3
41 Antirheumatic Agents Phase 4,Phase 3,Phase 2
42 Antitubercular Agents Phase 4,Phase 3
43 Bronopol Phase 4,Phase 3,Phase 2
44 Chelating Agents Phase 4,Phase 3
45 Cortisol succinate Phase 4,Phase 3,Phase 2
46 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
47 Gold Sodium Thiosulfate Phase 4,Phase 3
48 Hydrocortisone 17-butyrate 21-propionate Phase 4,Phase 3,Phase 2
49 Hydrocortisone acetate Phase 4,Phase 3,Phase 2
50 Hydrocortisone-17-butyrate Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 389)
id Name Status NCT ID Phase
1 Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Unknown status NCT01797562 Phase 4
2 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4
3 Quaternium-15, Use Test Unknown status NCT00311454 Phase 4
4 VANOS Cream and Skin Barrier Function Unknown status NCT00819507 Phase 4
5 Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) Unknown status NCT01781663 Phase 4
6 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4
7 Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) Unknown status NCT01553032 Phase 4
8 The Randomized Controlled Clinical Trial of Kushen Injection Unknown status NCT02346318 Phase 4
9 Effect of Moisturizing Creams on Skin Barrier Function Unknown status NCT00771121 Phase 4
10 Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis Completed NCT00667056 Phase 4
11 Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents Completed NCT00795951 Phase 4
12 Bioequivalence of Ethylenediamine Dihydrochloride Study Completed NCT01798589 Phase 4
13 Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance) Completed NCT00497692 Phase 4
14 Dermacyd Infantile (Lactic Acid)- Compatibility. Completed NCT00881374 Phase 4
15 Dermacyd Infantile (Lactic Acid) - Photo Evaluation. Completed NCT00881348 Phase 4
16 A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne Completed NCT00887484 Phase 4
17 A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne Completed NCT00964223 Phase 4
18 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed NCT00702507 Phase 4
19 Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash Completed NCT00219466 Phase 4
20 A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis Completed NCT00666302 Phase 4
21 Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis Completed NCT00666159 Phase 4
22 Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis Completed NCT00667160 Phase 4
23 Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis Completed NCT00673725 Phase 4
24 A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis Completed NCT00106496 Phase 4
25 Protopic Ointment in Children Atopic Eczema Completed NCT00689832 Phase 4
26 Protopic Ointment in Adult Atopic Eczema of the Face Completed NCT00690105 Phase 4
27 Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Recruiting NCT02716415 Phase 4
28 Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Recruiting NCT02495064 Phase 4
29 Topical Steroid Formulation and Wet Wraps Recruiting NCT02680301 Phase 4
30 Evaluating Treatment Resistant Dermatitis TaroIIR Recruiting NCT03050294 Phase 4
31 Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients Recruiting NCT03055494 Phase 4
32 Electrolyte Profile, Nutritional Status and Ileostomy Formation. Recruiting NCT02036346 Phase 4
33 Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema Recruiting NCT02601222 Phase 4
34 Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Recruiting NCT02550080 Phase 4
35 G-CSF in the Treatment of Toxic Epidermal Necrolysis Recruiting NCT02739295 Phase 4
36 Effectiveness of a Combined Dermatological Treatment in Children With Atopic Dermatitis Not yet recruiting NCT02920411 Phase 4
37 Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children? Not yet recruiting NCT02534467 Phase 4
38 Early Intervention With Lipid-Rich Barrier Cream in Infants at High Risk of Atopy Not yet recruiting NCT03089476 Phase 4
39 Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis Withdrawn NCT01167465 Phase 4
40 Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis Unknown status NCT01011621 Phase 3
41 Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis Unknown status NCT02286700 Phase 3
42 Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis Unknown status NCT01239719 Phase 3
43 Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment Unknown status NCT01257061 Phase 3
44 BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease Unknown status NCT00123916 Phase 3
45 Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy Completed NCT00640614 Phase 3
46 Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene Completed NCT00380991 Phase 3
47 Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene Completed NCT00371852 Phase 3
48 Dermacyd Teen Care Tangerina Mix - Compatibility Completed NCT00761800 Phase 3
49 Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina Mix Completed NCT00669058 Phase 3
50 Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet Flower Completed NCT00668668 Phase 3

Search NIH Clinical Center for Contact Dermatitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: dermatitis, contact

Genetic Tests for Contact Dermatitis

Anatomical Context for Contact Dermatitis

MalaCards organs/tissues related to Contact Dermatitis:

39
Skin, Testes, T Cells, Eye, Lung, Monocytes, Endothelial

Publications for Contact Dermatitis

Articles related to Contact Dermatitis:

(show top 50) (show all 1082)
id Title Authors Year
1
Diagnosis and management of allergic contact dermatitis in children: common allergens that can be easily missed. ( 28525402 )
2017
2
Wet Wipe Allergens: Retrospective Analysis From the North American Contact Dermatitis Group 2011-2014. ( 28002231 )
2017
3
Allergic Contact Dermatitis to 3-o-Ethyl-L-Ascorbic Acid in Skin-lightening Cosmetics. ( 28002235 )
2017
4
Occupational allergic contact dermatitis caused by benzisothiazolinone in printing ink and soap. ( 27957753 )
2017
5
Allergic contact dermatitis caused by exfoliating socks. ( 27957756 )
2017
6
Allergic Contact Dermatitis Due to Methylisothiazolinone in a Young Girl's Laundry Detergent. ( 28523864 )
2017
7
Occupational allergic contact dermatitis caused by tetracaine in an otorhinolaryngologist. ( 27957755 )
2017
8
Occupational Allergic Contact Dermatitis due to Multiple Tropical Plant Species. ( 28529083 )
2017
9
Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet. ( 27957750 )
2017
10
Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014. ( 28002236 )
2017
11
Acral manifestations of contact dermatitis. ( 27938818 )
2017
12
Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis. ( 27981502 )
2017
13
Allergic Contact Dermatitis. ( 27886903 )
2017
14
The "Jewelry Addict": Allergic Contact Dermatitis from Repetitive Multiple Children's Jewelry Exposures. ( 27001330 )
2016
15
GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice. ( 27527650 )
2016
16
The Association of Race/Ethnicity and Patch Test Results: North American Contact Dermatitis Group, 1998-2006. ( 27649352 )
2016
17
Response to letter to the editor re. Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace. ( 27878862 )
2016
18
Allergic contact dermatitis to balsam of Peru. ( 27499544 )
2016
19
As in Atopic Dermatitis, Nonlesional Skin inA Allergic Contact Dermatitis Displays Abnormalities in Barrier Function and Ceramide Content. ( 27826010 )
2016
20
Allergic contact dermatitis caused by cocamide diethanolamine. ( 27144883 )
2016
21
Herpetol ameliorates allergic contact dermatitis through regulating T-lymphocytes. ( 27588913 )
2016
22
Patch Testing for Evaluation of Hypersensitivity to Implanted Metal Devices: A Perspective From the American Contact Dermatitis Society. ( 27649347 )
2016
23
Patch Testing in Children and Adolescents With Suspected Allergic Contact Dermatitis. ( 27784513 )
2016
24
Allergic Contact Dermatitis from Topical Acyclovir: Case Series. ( 27658557 )
2016
25
Allergic Contact Dermatitis Caused by P-Tert-Butylphenol-Formaldehyde Resin in Orthopedic Braces. ( 27071627 )
2016
26
Allergic contact dermatitis caused by phenylethyl resorcinol, a skin-lightening agent contained in a sunscreen. ( 27620125 )
2016
27
Allergic contact dermatitis to parthenolide. ( 27161148 )
2016
28
Airborne allergic contact dermatitis caused by a henna stone. ( 27480518 )
2016
29
Influence of vitamin C on the elicitation of allergic contact dermatitis to p-phenylenediamine. ( 27027508 )
2016
30
Patch tests with commercial hair dye products in patients with allergic contact dermatitis to para-phenylenediamine. ( 27451929 )
2016
31
Allergic contact dermatitis: Patient diagnosis and evaluation. ( 27185421 )
2016
32
Effectiveness of the European Chromium VI Directive for cement implementation on occupational allergic contact dermatitis occurrence: Assessment in France and UK. ( 28008593 )
2016
33
Pigmented Contact Dermatitis Resulting from Self-medication for Postherpetic Neuralgia. ( 27293266 )
2016
34
Allergic contact dermatitis caused by the tea tree oil-containing hydrogel Burnshield(Ar). ( 27040879 )
2016
35
Contact allergy to sulfites: clinical and occupational relevance - new data from the German Contact Dermatitis Research Group and the Information Network of Departments of Dermatology (IVDK). ( 27607044 )
2016
36
Hair-care practices in African American women: potential for allergic contact dermatitis. ( 27918002 )
2016
37
Anogenital allergic contact dermatitis caused by methylchloroisothiazolinone, methylisothiazolinone and topical clotrimazole with subsequent generalized exanthem triggered by oral fluconazole. ( 27040872 )
2016
38
What Drives Healthcare Worker Actions to Treat Irritant Contact Dermatitis on Hands? ( 27174158 )
2016
39
Leather Contains Cobalt and Poses a Risk of Allergic Contact Dermatitis: Cobalt Indicator Solution and X-ray Florescence Spectrometry as Screening Tests. ( 27427822 )
2016
40
Pediatric Contact Dermatitis Registry Inaugural Case Data. ( 27649353 )
2016
41
Octylisothiazolinone, an additional cause of allergic contact dermatitis caused by leather: case series and potential implications for the study of cross-reactivity with methylisothiazolinone. ( 27538353 )
2016
42
An unusual complication of minor surgery: contact dermatitis caused by injected lidocaine. ( 27620126 )
2016
43
Airborne contact dermatitis caused by the sarcotesta of Ginkgo biloba. ( 27870101 )
2016
44
Acetophenone azine: a new allergen responsible for severe contact dermatitis from shin pads. ( 27198908 )
2016
45
Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak? ( 27579576 )
2016
46
Systemic contact dermatitis caused by inhaled cashew oil smoke. ( 27620124 )
2016
47
Allergic contact dermatitis from acrylic nails in a flamenco guitarist. ( 27834227 )
2016
48
Social Awareness Within Reach-Lessons from Pediatric Contact Dermatitis. ( 27882667 )
2016
49
Propolis, Colophony, and Fragrance Cross-Reactivity and Allergic Contact Dermatitis. ( 27172306 )
2016
50
Roseotoxin B Improves Allergic Contact Dermatitis through a Unique Anti-inflammatory Mechanism Involving Excessive Activation of Autophagy in Activated T-Lymphocytes. ( 27155460 )
2016

Variations for Contact Dermatitis

Expression for Contact Dermatitis

Search GEO for disease gene expression data for Contact Dermatitis.

Pathways for Contact Dermatitis

Pathways related to Contact Dermatitis according to GeneCards Suite gene sharing:

(show top 50) (show all 80)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
14.13 CXCL8 ICAM1 IFNG IL10 IL17A IL1A
2
Show member pathways
13.94 CCL17 CXCL8 CXCR3 IL10 IL17A IL1A
3
Show member pathways
13.78 CCL17 CXCL8 CXCR3 IFNG IL10 IL17A
4
Show member pathways
13.67 CCL17 CXCL8 ICAM1 IFNG IL10 IL17A
5
Show member pathways
13.55 CCL17 CXCL8 CXCR3 IL10 IL17A IL1A
6
Show member pathways
13.5 CXCL8 ICAM1 IFNG IL10 IL17A IL1A
7
Show member pathways
13.44 CCL17 CXCL8 CXCR3 IL10 IL17A IL1A
8
Show member pathways
13.07 CXCL8 IL1A IL1B IL33 IL6 TNF
9
Show member pathways
13 CXCL8 IFNG IL10 IL1B IL6 TNF
10
Show member pathways
13 CXCL8 ICAM1 IFNG IL10 IL17A IL1A
11
Show member pathways
12.96 CXCL8 ICAM1 IFNG IL1A IL1B IL33
12
Show member pathways
12.85 CXCL8 IFNG IL1B IL33 IL6 TNF
13
Show member pathways
12.78 IFNG IL10 IL17A IL1A IL1B IL4
14
Show member pathways
12.73 IFNG IL10 IL17A IL1B IL6 TNF
15 12.69 IFNG IL10 IL17A IL1B IL4 TNF
16
Show member pathways
12.62 IFNG IL10 IL17A IL1A IL1B IL4
17
Show member pathways
12.53 CCL17 CXCL8 IFNG IL17A IL1B IL4
18
Show member pathways
12.51 ICAM1 IFNG IL1B IL4 IL6 TNF
19
Show member pathways
12.45 CXCL8 IFNG IL1A IL1B IL6 TNF
20
Show member pathways
12.44 IFNG IL10 IL1A IL1B IL4 TNF
21 12.42 IFNG IL10 IL1A IL1B IL6 TNF
22
Show member pathways
12.37 CXCL8 IFNG IL1B IL4 IL6 TNF
23
Show member pathways
12.36 IFNG IL10 IL4 IL5 IL6
24 12.36 CXCL8 IL10 IL1A IL1B IL6 TNF
25
Show member pathways
12.33 CXCL8 IL1A IL6 TNF
26 12.28 ICAM1 IFNG IL1A IL1B SELE TNF
27
Show member pathways
12.28 CXCL8 IFNG IL10 IL17A IL1A IL1B
28 12.22 CXCL8 ICAM1 IFNG IL1A IL1B IL4
29 12.2 IFNG IL10 IL4 IL5 IL6 TNF
30 12.17 CXCL8 ICAM1 IL10 IL17A IL1A IL1B
31 12.15 IFNG IL1A IL1B TNF
32
Show member pathways
12.15 IFNG IL10 IL17A IL1B IL6 TNF
33 12.14 ICAM1 IL1B IL6 SELE TNF
34 12.13 CXCL8 IFNG IL1A IL1B IL6
35 12.12 CXCL8 ICAM1 IL1A IL1B IL6 SELE
36
Show member pathways
12.11 IFNG IL17A IL1B IL4 IL6
37 12.1 IL1A IL1B IL4 IL5 IL6 TNF
38 12.09 CXCL8 IFNG IL10 IL1B IL6 TNF
39 12.05 CXCL8 ICAM1 IFNG IL17A IL1A IL1B
40 12.03 CXCL8 IFNG IL1A IL1B IL6
41 12.03 CXCL8 ICAM1 IFNG IL4 IL5 IL6
42 12.01 CXCL8 ICAM1 IL1B TNF
43
Show member pathways
12 CXCL8 ICAM1 IL17A IL6
44 11.97 CXCL8 IL10 IL1A IL1B IL6 TNF
45
Show member pathways
11.96 CXCL8 IFNG IL4 IL5 TNF
46 11.96 IFNG IL10 IL1B IL6 TNF
47 11.93 ICAM1 IL10 IL4 IL5 IL6 TNF
48 11.88 CXCR3 IFNG IL10 IL17A IL1B IL33
49 11.87 CXCL8 IL1B IL4 IL5 IL6 TNF
50
Show member pathways
11.83 CXCL8 ICAM1 IFNG IL1A IL1B IL6

GO Terms for Contact Dermatitis

Cellular components related to Contact Dermatitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.97 CCL17 CXCL8 IFNG IL10 IL17A IL1A
2 external side of plasma membrane GO:0009897 9.5 CXCR3 ICAM1 IFNG IL17A IL4 IL6
3 extracellular space GO:0005615 9.5 CCL17 CXCL8 ICAM1 IFNG IL10 IL17A

Biological processes related to Contact Dermatitis according to GeneCards Suite gene sharing:

(show top 50) (show all 74)
id Name GO ID Score Top Affiliating Genes
1 chemotaxis GO:0006935 9.99 CCL17 CXCL8 CXCR3 IL4
2 positive regulation of protein phosphorylation GO:0001934 9.99 IFNG IL1B IL4 TNF
3 cytokine-mediated signaling pathway GO:0019221 9.99 IL1A IL1B IL5 IL6
4 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.97 ICAM1 IL1B IL6 TNF
5 cellular response to tumor necrosis factor GO:0071356 9.95 CCL17 CXCL8 ICAM1 IL6
6 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.92 ICAM1 IL4 IL5 IL6
7 movement of cell or subcellular component GO:0006928 9.91 CXCL8 CXCR3 IFNG
8 response to glucocorticoid GO:0051384 9.91 IL10 IL6 TNF
9 chemokine-mediated signaling pathway GO:0070098 9.91 CCL17 CXCL8 CXCR3
10 response to insulin GO:0032868 9.91 ICAM1 IL10 IL6
11 regulation of insulin secretion GO:0050796 9.9 IFNG IL1B TNF
12 humoral immune response GO:0006959 9.89 IFNG IL6 TNF
13 calcium-mediated signaling GO:0019722 9.88 CXCL8 CXCR3 SELE
14 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.88 IFNG IL4 IL6
15 neutrophil chemotaxis GO:0030593 9.88 CCL17 CXCL8 IFNG IL1B
16 cellular response to interleukin-1 GO:0071347 9.88 CCL17 CXCL8 ICAM1 IL17A IL6
17 cellular response to lipopolysaccharide GO:0071222 9.88 CXCL8 ICAM1 IFNG IL10 IL6 TNF
18 extrinsic apoptotic signaling pathway GO:0097191 9.86 IFNG IL33 TNF
19 positive regulation of T cell proliferation GO:0042102 9.86 IFNG IL1B IL4 IL6
20 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.84 IL1A IL1B TNF
21 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.82 IL1A IL1B IL4
22 positive regulation of cytokine secretion GO:0050715 9.81 IL10 IL1A TNF
23 negative regulation of endothelial cell apoptotic process GO:2000352 9.81 ICAM1 IL10 IL4
24 positive regulation of osteoclast differentiation GO:0045672 9.79 IFNG IL17A TNF
25 negative regulation of growth of symbiont in host GO:0044130 9.77 IFNG IL10 TNF
26 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.77 IFNG IL1B TNF
27 positive regulation of interleukin-6 production GO:0032755 9.77 IL1A IL1B IL33 IL6 TNF
28 negative regulation of nitric oxide biosynthetic process GO:0045019 9.75 IL10 IL4
29 response to molecule of bacterial origin GO:0002237 9.75 CXCL8 IL10
30 positive regulation of macrophage activation GO:0043032 9.75 IL10 IL33
31 positive regulation of podosome assembly GO:0071803 9.74 IL5 TNF
32 cellular response to nutrient levels GO:0031669 9.74 ICAM1 IL6
33 positive regulation of interleukin-2 biosynthetic process GO:0045086 9.74 IL1A IL1B
34 positive regulation of protein import into nucleus, translocation GO:0033160 9.74 IFNG IL6
35 positive regulation of isotype switching to IgG isotypes GO:0048304 9.74 IFNG IL4
36 negative regulation of lipid storage GO:0010888 9.73 IL6 TNF
37 positive regulation of interleukin-6 biosynthetic process GO:0045410 9.73 IFNG IL1B
38 defense response to protozoan GO:0042832 9.73 IFNG IL10 IL4 IL6
39 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.73 IL10 IL1B IL4 IL5 IL6 TNF
40 positive regulation of monocyte chemotactic protein-1 production GO:0071639 9.72 IL1A IL1B
41 endothelial cell apoptotic process GO:0072577 9.72 IL10 TNF
42 positive regulation of interleukin-13 production GO:0032736 9.72 IL33 IL4
43 regulation of defense response to virus by host GO:0050691 9.72 IFNG IL1B
44 ectopic germ cell programmed cell death GO:0035234 9.72 IL1A IL1B
45 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.72 IL10 IL1B TNF
46 positive regulation of nitric oxide biosynthetic process GO:0045429 9.72 ICAM1 IFNG IL1B IL6 TNF
47 regulation of establishment of endothelial barrier GO:1903140 9.71 IL1B TNF
48 negative regulation of cytokine secretion involved in immune response GO:0002740 9.71 IL10 TNF
49 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 9.71 IL6 TNF
50 positive regulation of immunoglobulin secretion GO:0051024 9.71 IL33 IL5 IL6

Molecular functions related to Contact Dermatitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.44 CCL17 CXCL8 IFNG IL10 IL17A IL1A
2 growth factor activity GO:0008083 9.26 IL10 IL4 IL5 IL6

Sources for Contact Dermatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....